Q32 Bio Inc. (QTTB) Change in Accured Expenses (2017 - 2026)

Q32 Bio has reported Change in Accured Expenses for 10 years, with the latest figure at $39000.0 in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 104.39% year-over-year to $39000.0 in Q2 2026; TTM through Jun 2026 was -$642000.0, a 89.16% increase from a year earlier, with the FY2025 full-year figure at -$3.3 million, up 56.86% from the prior year.
• Change in Accured Expenses was $39000.0 for Q2 2026 at Q32 Bio, up from -$476000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $6.6 million in Q2 2022, with the low at -$5.0 million in Q1 2022.
• Average Change in Accured Expenses over 5 years is -$214555.6, with a median of -$700000.0 recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses surged 172.56% in 2022, then sank 194.19% in 2024.
• Over 5 years, Change in Accured Expenses stood at $1.7 million in 2022, then surged by 34.42% to $2.3 million in 2023, then plunged by 143.37% to -$1.0 million in 2024, then surged by 130.06% to $306000.0 in 2025, then tumbled by 87.25% to $39000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $39000.0 (Q2 2026), -$476000.0 (Q1 2026), and $306000.0 (Q4 2025), per Business Quant data.